Intent to Sole Source - Detachable Coils
Closed Special Notice Posted
- Solicitation number
- NOI-CC-OLAO-26-008070
- Agency
-
National Institutes of Health
Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 339112 Surgical and Medical Instrument Manufacturing
- Place of performance
- Bethesda, Maryland 20892, United States
Notice details come from SAM.gov. Updated .
About this opportunity
The National Institute of Health, Clinical Center issued a Notice of Intent on July 16, 2026 to sole-source a requirement for detachable coils to Medtronic USA Inc., with a deadline of July 20, 2026 at 12:00 PM ET for alternative capability statements. The acquisition will proceed on other than full and open competition basis under 41 U.S.C. 253(c)(1) and FAR 6.302-1, citing only one responsible source for the requirement.
The coils are used for arterial embolization to stop internal bleeding and save life, or to deliberately occlude blood flow to ablate tumors. Medtronic's CONCERTO COILS come in various micro and macro diameters and deploy into shapes that conform and constrict blood vessels while minimizing trauma to surrounding vasculature and complications. The acquisition encompasses a comprehensive continuum of care from patient assessment through hemostasis or tumor ablation.
Any responsible source capable of providing the required products may submit a capability statement by the July 20 deadline. Responses should be submitted by email to valerie.gregorio@nih.gov with subject line referencing the solicitation number NOI-CC-OLAO-26-008078. The Government will consider all responses received by the closing date and retains sole discretion to determine whether to compete the requirement based on the submissions received.
Notice text
This is a Notice of Intent, not a request for proposal. The National Institute of Health, Clinical Center (NIH-CC) intends to negotiate on an other than full and open competition basis with the following vendor: Medtronic USA Inc.
Acquisition Background:
The purpose of this acquisition is to stop internal bleeding/ blood flow. The coils are used to occlude internal bleeding and save life. An alternation therapy also includes deliberate blocking of blood flow to kill a tumor. The CONCERTO COILS come in an array of various diameters, both micro and macro, and deploy into various shapes to conform and constrict the blood vessel. The Embolization and resulting Occlusion of an artery and its management require a specific and comprehensive category of products, solutions and services to enable providing a continuum of care, from patient assessment to stopping a bleed, or embolizing blood flow to ablate a tumor, these products are designed to do the job with little trauma to the vasculature in the surrounding areas/tissue, minimal complications.
The statutory authority for this sole source requirement is 41 U.S.C. 253(c) (1) as implemented by FAR 6.302-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A REQUEST FOR PROPOSAL. All responsible sources that could provide the required may submit a capability statement that will be considered by email (subject line to reference NOI-CC-OLAO-26-008078) by 12:00 PM eastern standard time on 07/20/2026 to: valerie.gregorio@nih.gov.
All responses received by the closing date of this synopsis will be considered by the Government. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.
NOTE: The actual soliciation number is NOI-CC-OLAO-26-008078. SAM.gov would not let me update the solication number listed.
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Notice of Intent to Sole Source – Boston Scientific | NIH Clinical Center | No set-aside | |
| Intent to Sole Source - Medical/Scientific Instruments for the Department of Transfusion Medicine, NIH Clinical Center | National Institutes of Health | No set-aside | |
| Intent to Sole Source - BD FACSCanto II instrument | National Institutes of Health | No set-aside | |
| Intent to Sole Source - Fertility Preservation Lab Services | National Institutes of Health | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity